Related Experiment Videos
[Reversible dementia due to valproic acid therapy]
1Academisch Medisch Centrum, afd. Neurologie, Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|February 22, 1997
Summary
Valproate therapy can cause reversible dementia with frontal-subcortical features. Discontinuing valproate led to complete recovery, highlighting the importance of considering drug-induced cognitive decline.
Area of Science:
- Neurology
- Geriatrics
- Pharmacology
Background:
- Dementia is a progressive decline in cognitive function.
- Frontal-subcortical dementia presents with specific cognitive and behavioral changes.
- Drug-induced dementia is a recognized but often overlooked cause of cognitive impairment.
Observation:
- A 72-year-old woman developed progressive dementia with frontal-subcortical features.
- The dementia symptoms emerged during valproate (Depakine) therapy.
Findings:
- Discontinuation of valproate therapy resulted in the complete resolution of dementia symptoms.
- This case suggests a rare but direct association between valproate and reversible dementia.
Implications:
- Frontal-subcortical dementia features may indicate a reversible etiology.
- Clinicians should consider drug-induced causes, including valproate, in patients presenting with cognitive decline.
- Early identification and discontinuation of causative agents can lead to full recovery from dementia.